BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6773704)

  • 1. A revised fluorometric assay for Gaucher's disease using conduritol-beta-epoxide with liver as the source of Beta-glucosidase.
    Daniels LB; Glew RH; Radin NS; Vunnam RR
    Clin Chim Acta; 1980 Sep; 106(2):155-63. PubMed ID: 6773704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An improved fluorometric leukocyte beta-glucosidase assay for Gaucher's disease.
    Daniels LB; Glew RH; Diven WF; Lee RE; Radin NS
    Clin Chim Acta; 1981 Sep; 115(3):369-75. PubMed ID: 6794954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of a cytosolic broad specificity beta-glucosidase from human liver.
    Daniels LB; Coyle PJ; Chiao YB; Glew RH; Labow RS
    J Biol Chem; 1981 Dec; 256(24):13004-13. PubMed ID: 6796580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of various beta-glucosidase assays used to diagnose Gaucher's disease.
    Chiao YB; Glew RH; Diven WF; Lee RE
    Clin Chim Acta; 1980 Jul; 105(1):41-50. PubMed ID: 6772352
    [No Abstract]   [Full Text] [Related]  

  • 5. Brain glucocerebrosidase in Gaucher's disease.
    Daniels LB; Coyle PJ; Glew RH; Radin NS; Labow RS
    Arch Neurol; 1982 Sep; 39(9):550-6. PubMed ID: 6810854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of 4-heptylumbelliferyl-beta-D-glucoside to identify Gaucher's disease heterozygotes.
    Butcher BA; Gopalan V; Lee RE; Richards TC; Waggoner AS; Glew RH
    Clin Chim Acta; 1989 Oct; 184(3):235-42. PubMed ID: 2515009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.
    Glew RH; Daniels LB; Clark LS; Hoyer SW
    J Neuropathol Exp Neurol; 1982 Nov; 41(6):630-41. PubMed ID: 6813430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaucher-like changes in human blood-derived macrophages induced by beta-glucocerebrosidase inhibition.
    Yatziv S; Newburg DS; Livni N; Barfi G; Kolodny EH
    J Lab Clin Med; 1988 Apr; 111(4):416-20. PubMed ID: 3351378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of N-acyl phosphatidylethanolamines with different N-acyl groups as activators of glucocerebrosidase in various forms of Gaucher's disease.
    Basu A; Prence E; Garrett K; Glew RH; Ellingson JS
    Arch Biochem Biophys; 1985 Nov; 243(1):28-34. PubMed ID: 3933429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pitfalls in the use of artificial substrates for the diagnosis of Gaucher's disease.
    Ben-Yoseph Y; Nadler HL
    J Clin Pathol; 1978 Nov; 31(11):1091-3. PubMed ID: 105017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid beta-glucosidase and the diagnosis of Gaucher's disease in liver and spleen.
    Butterworth J; Broadhead DM
    Clin Chim Acta; 1978 Aug; 87(3):433-40. PubMed ID: 28186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Glucosidase assays in the diagnosis of Gaucher's disease.
    Daniels LB; Glew RH
    Clin Chem; 1982 Apr; 28(4 Pt 1):569-77. PubMed ID: 6804115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the activation of rat liver beta-glucosidase by sialosylgangliotetraosylceramide.
    Basu A; Glew RH
    J Biol Chem; 1985 Oct; 260(24):13067-73. PubMed ID: 3932339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sucrose gradient analysis of phospholipid-activated beta-glucosidase in type 1 and type 2 Gaucher's disease.
    Garrett KO; Prence EM; Glew RH
    Arch Biochem Biophys; 1985 Apr; 238(1):344-52. PubMed ID: 3920967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the phospholipid requirement of a rat liver beta-glucosidase.
    Basu A; Glew RH
    Biochem J; 1984 Dec; 224(2):515-24. PubMed ID: 6517862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-beta-glucosidase activity in the liver.
    Owada M; Sakiyama T; Kitagawa T
    Pediatr Res; 1977 May; 11(5):641-6. PubMed ID: 870871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Beta-glucosidases. Molecular bases of Gaucher's disease].
    Maret A; Salvayre R; Negre A; Douste-Blazy L
    Pathol Biol (Paris); 1985 Jun; 33(6):693-713. PubMed ID: 3931039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,3-di-O-tetradecyl-1-O-(beta-D-glucopyranosyl)-sn-glycerol is a substrate for human glucocerebrosidase.
    Glew RH; Gopalan V; Hubbell CA; Devraj RV; Lawson RA; Diven WF; Mannock DA
    Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):557-63. PubMed ID: 1900989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectors of three beta-glucosidases from human liver.
    Daniels LB; Gnarra JR; Glew RH
    Prog Clin Biol Res; 1982; 95():333-55. PubMed ID: 6812077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gaucher's disease.
    Patel AL; Shaikh WA; Khobragade AK; Soni HG; Joshi AS; Sahasrabudhe GS; Chole PV
    J Assoc Physicians India; 2009 May; 57():410-1. PubMed ID: 19634291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.